Try our free ADHD Screening Tool Next available appointment: typically 6 to 8 weeks Book now →
Library guide ADHD Foundations For women, families and parents

Why ADHD Looks Different in Girls and Women

Why ADHD in girls and women is often missed: the inattentive presentation, masking, hormonal effects, and what assessment looks like for women in the UK.

Reviewed 16 Jul 2025 Next review Jul 2026 ~1,500 words · 8 min read Clinically reviewed

ADHD in girls and women is one of the most reliably missed clinical pictures in modern psychiatry. The presentation often looks different from the stereotype, the diagnostic criteria were developed largely from male samples, and the system has historically not been built to spot it [1, 2]. This article explains what the actual female presentation looks like, why it gets missed, and what a proper assessment covers.

The pattern, in short

In clinical samples, girls and women with ADHD are more likely to:

  • Present with the inattentive rather than the hyperactive-impulsive presentation [1, 2].
  • Mask traits effectively, often by working harder, internalising difficulty, or copying neurotypical peers [1, 2].
  • Have co-occurring anxiety, low mood, eating difficulties or self-esteem problems by the time they reach assessment [1, 2].
  • Reach diagnosis years or decades later than their male peers, often after a child or partner is diagnosed first [1].

The female-to-male ratio in research samples sits at around one to two for ADHD, but in routine clinical referrals it can be closer to one to ten in childhood [1, 2]. The gap is not biology; it is recognition.

How ADHD shows up differently in girls

Girls with ADHD are often well-behaved on the surface. They tend to be the quiet daydreamer in row three, not the disruptive child at the back. Common features include:

  • Sustained difficulty getting started and finishing tasks; appearing "lazy" or "scatty"
  • Lost belongings; permanently chaotic bedroom or schoolbag
  • Difficulty with friendship dynamics, particularly social hierarchies and unwritten rules
  • Sensitivity to criticism that looks like fragility
  • Emotional intensity, mood swings, frequent tears in primary school
  • High effort to keep up academically, often with stress and exhaustion behind closed doors
  • Talkativeness in safe settings, alongside selective mutism or shutdown in others

A small number of girls do present with the classic hyperactive-impulsive picture, but they are the minority. Most are missed because they do not match what teachers, GPs and even some clinicians expect ADHD to look like.

ADHD in women is consistently missed, misread and misunderstood covers the cultural and clinical reasons for that in detail.

How ADHD shows up in adult women

Adult women with ADHD typically reach assessment with a stack of secondary problems before the primary one is recognised. Common features include:

  • Chronic overwhelm with daily admin, despite being externally capable
  • A persistent gap between intention and follow-through
  • Emotional dysregulation, especially around premenstrual phases and around perimenopause
  • Long-running anxiety or low mood
  • A history of disordered eating, alcohol or stimulant use as self-medication
  • Burnout, often misattributed to a single demanding job or to motherhood
  • A tendency to internalise blame; the language is usually "I should be able to do this"

Masking is central. Women with ADHD often expend significant cognitive and emotional effort to look organised, calm and competent in public, then collapse at home. This pattern is one of the reasons female ADHD is so often missed by short clinical appointments: the patient performs well in the room.

Hormones change the picture

Oestrogen modulates dopamine. Studies in the past decade have established that ADHD symptoms in women are not stable across the menstrual cycle [4, 5]:

  • Symptoms tend to worsen in the late luteal phase (the week before menstruation), when oestrogen and progesterone are dropping.
  • Symptoms often soften in the early follicular and ovulatory phases, when oestrogen rises.
  • In perimenopause, falling oestrogen is associated with a meaningful worsening of ADHD symptoms in many women, which is why many present for assessment for the first time in their forties or fifties.

This is not a soft observation. It has implications for diagnosis, for medication titration, and for treatment planning. A clinician who is not asking about cycle, perimenopause and hormonal status is missing a substantial part of the picture.

Why girls and women get missed

A few specific reasons account for most missed diagnoses:

  • The inattentive presentation does not disrupt the classroom. Quiet, daydreamy girls rarely trigger school concerns until grades or anxiety start sliding.
  • Diagnostic criteria were developed mostly from male samples. Although DSM-5-TR has improved on this, the symptom examples still skew male in places [1, 2].
  • High effort masks underlying difficulty. Bright, hardworking girls coast through school on intelligence and structured environments, then meet difficulty at university, in their first job, or when they become a parent.
  • Co-occurring anxiety or depression takes the spotlight. The presenting complaint is the mood symptom. The underlying ADHD never gets asked about.
  • Gendered expectations. A girl who is forgetful, dreamy and emotionally intense often gets framed as anxious, sensitive or a "people-pleaser" rather than as a candidate for ADHD assessment.

What a proper assessment looks like

NICE NG87 requires a full clinical interview that captures both current and developmental symptoms, across multiple settings, with a careful differential diagnosis for co-occurring conditions [6]. For women specifically, a good assessment also probes:

  • The pattern of difficulty across the menstrual cycle and any hormonal transitions
  • Childhood functioning, often with school reports or a family informant
  • Masking behaviour and the home/public split in functioning
  • Eating, alcohol or sleep patterns as potential self-medication
  • Co-occurring anxiety, depression, autism, PMDD and trauma

NeuroFX offers a private adult ADHD assessment for women that explicitly addresses these factors. The same NICE standard applies whether the assessment is delivered through the NHS, via Right to Choose in England, or privately via a private adult ADHD assessment.

What this means in practice

  • If you have wondered for years whether you might have ADHD, your instinct is worth taking seriously. Late female diagnosis is one of the most common patterns in adult assessment today.
  • Bring as much developmental history as you can. Old school reports, parental input, photos of your bedroom at twelve. They all help.
  • Track your symptoms across at least one menstrual cycle if relevant. Patterns become visible that single snapshots miss.
  • Do not let a previous assessment for anxiety or depression settle the matter. Co-occurring mood symptoms in a woman with ADHD are common, not exclusionary.

When to speak to a professional

Speak to your GP if the pattern fits across more than one setting and dates back to childhood. NHS routes include GP referral and Right to Choose in England. NeuroFX offers private adult ADHD assessment for women from our Bedford clinic. Seek same-day support via 111 (or 999 in an emergency) for any mental health crisis, including disordered eating in crisis.

Sources

  1. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews. 2021;128:789-818.
  2. Hinshaw SP, Nguyen PT, O'Grady SM, Rosenthal EA. Annual Research Review: Attention-deficit/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directions. Journal of Child Psychology and Psychiatry. 2022;63(4):484-496.
  3. Quinn PO, Madhoo M. A review of attention-deficit/hyperactivity disorder in women and girls: uncovering this hidden diagnosis. Primary Care Companion for CNS Disorders. 2014;16(3):PCC.13r01596.
  4. Roberts B, Eisenlohr-Moul T, Martel MM. Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology. 2018;88:105-114.
  5. Eng AG, Nirjar U, Elkins AR, et al. Attention-deficit/hyperactivity disorder and the menstrual cycle: Theory and evidence. Hormones and Behavior. 2024;158:105466.
  6. NICE. Attention deficit hyperactivity disorder: diagnosis and management. NG87. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng87

References & evidence

Last reviewed 16 Jul 2025. Next scheduled review: Jul 2026. Reviewed by Tina Fox, Specialist Neurodevelopmental Practitioner & Independent Prescriber.

  1. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789-818.
  2. Hinshaw SP, Nguyen PT, O'Grady SM, Rosenthal EA. Annual Research Review: Attention-deficit/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directions. J Child Psychol Psychiatry. 2022;63(4):484-496.
  3. Quinn PO, Madhoo M. A review of attention-deficit/hyperactivity disorder in women and girls: uncovering this hidden diagnosis. Prim Care Companion CNS Disord. 2014;16(3):PCC.13r01596.
  4. Roberts B, Eisenlohr-Moul T, Martel MM. Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology. 2018;88:105-114.
  5. Eng AG, Nirjar U, Elkins AR, et al. Attention-deficit/hyperactivity disorder and the menstrual cycle: Theory and evidence. Horm Behav. 2024;158:105466.
  6. NICE. Attention deficit hyperactivity disorder: diagnosis and management. NG87. https://www.nice.org.uk/guidance/ng87
Tina Fox
Reviewed by

Tina Fox

Specialist Neurodevelopmental Practitioner & Independent Prescriber

Tina is Clinical Lead at NeuroFX, with 15 years of specialist mental health nursing experience and as an advanced specialist paediatric sleep practitioner. She personally leads NeuroFX assessments and prescribing, and clinically reviews the guidance published here against current NICE standards.

Read Tina's full profile →
WhatsApp Call us Book